• Drug Coverage
  • Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Safety & Recalls
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Utilization, Revenue Cratered for Healthcare Specialties in March, April


Utilization and revenue were half of March and April 2019 levels for oral surgery, cardiology, dermatology, gastroenterology, and orthopedics.

We know that people stopped going to the doctor when COVID-19 hit in March. FAIR Health, a not-for-profit with a large database that includes 150 million insured Americans and claims from 60 insurers and third-party administrators, put some numbers to that generalization in a report today.

Overall, the report shows that utilization of professional services declined by 65% in March 2020 compared with March 2019 and revenue (which FAIR Health calculates based on estimates of in-network fees) for the month flew 45%. In April, the drop-off was even steeper: a 68% decrease in utilization compared with April 2019 and a 48% decline in revenue.

The FAIR Health researchers also looked at seven specialties. Oral surgery had the largest declines in utilization and revenue while pediatric primary care had smallest. Cardiology, dermatology, gastroenterology and orthopedics all saw utilization and revenue declines in March  and April of well over 50% compared with those months a year ago. Pediatric and adult primary care also saw steep declines but not as steep as the declines for those four specialties

FAIR Health’s data showed little change in preventive care for newborns and children through the age of four. There has been some concern that other kinds of infectious diseases might take off if children stopped getting vaccinated. The FAIR Health claims data show some drop off in vaccinations - 14% decline in March compared with March 2019  and 10% decline in April compared with April 2019 – but decrease wasn’t as precipitous as many feared.

The report notes that evaluation and management (E&M) visits became more common relative to other procedures, both by utilization and revenue estimates. The report attributes the change to telehealth and the decline in procedures that require in-person care.

Related Videos
Video 3 - "In-Office Procedures, Over-the-Counter Options, Treatment Delays, and Costs"
Video 6 - "Safety Analysis and Interpreting Results from MAJIC-PV"
Video 5 - "Key Findings from MAJIC-PV"
Video 2 - "Traditional Treatment of Demodex Blepharitis, FDA approval, and Lotilaner Ophthalmic Solution, 0.25%"
Gabriela Hobbs, MD, an expert on polycythemia vera
Gabriela Hobbs, MD, and Timothy Mok, PharmD, BCPS, BCOP
Video 1 - "Demodex Blepharitis: Prevalence, Symptoms, Quality of Life Impact, and Diagnosis"
Video 2 - "The Role of Ruxolitinib in Managing Hydroxyurea Resistance or Intolerance"
Video 1 - "Prevalence and Impact of Hydroxyurea Intolerance or Resistance in Polycythemia Vera"
Related Content
© 2024 MJH Life Sciences

All rights reserved.